| Patent application number | Description | Published |
|---|
| 20090008558 | CAMERA AND METHOD FOR USE WITH CAMERA - A method of fusing IR image data and visible light image data corresponding to the same field of view in the same image is disclosed, comprising displaying IR image data in at least a first portion of the image and visible light image data in at least a second portion of the image. The method is characterized by the step of displaying the IR image data according to a colouring scheme adapted to the temperature range relevant for the first portion of the image. | 01-08-2009 |
| 20090010633 | CAMERA AND METHOD FOR USE WITH CAMERA - A camera comprising a first imaging part for capturing IR image data of a first field of view, said first imaging part comprising IR optics, a second imaging part for capturing visible light data of a second field of view at least partially overlapping the first field of view, said second imaging part comprising visible light optics, a laser pointer for providing a laser dot in the second field of view, and means for adjusting the first and second field of view relative to each other in dependence of the focusing distance of the first or second imaging part. The camera is arranged to determine the distance z between the camera and an object being imaged by means of the distance d, using the stored relationship. The distance z may be used to align the IR image and the visible light image. | 01-08-2009 |
| 20090010635 | CAMERA AND METHOD FOR USE WITH CAMERA - A camera comprising a first imaging part for capturing IR image data of a first field of view, said first imaging part comprising IR optics, a second imaging part for capturing visible light data of a second field of view at least partially overlapping the first field of view, said second imaging part comprising visible light optics, and means for adjusting the first and second field of view relative to each other in dependence of the focusing distance of the first or second imaging part. One of the imaging parts comprises a motor for focusing of the optics, respectively, said camera further comprising sensing means arranged to sense the position of the motor and processing means arranged to determine the displacement needed to align the images based on the position of the focus motor. | 01-08-2009 |
| Patent application number | Description | Published |
|---|
| 20090069285 | Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitor Activity - 2-azetidinone derivatives and pharmaceutical compositions containing them. The compounds are useful in the treatment of hyperlipidemic conditions, atherosclerosis, Alzheimers' disease and cholesterol associated tumours. | 03-12-2009 |
| 20100048529 | New 2-Azetidinone Derivatives Useful In The Treatment Of Hyperlipidaemic Conditions - The invention relates to compounds of formula (I) and pharmaceutically acceptable salts, solvates, and prodrugs thereof, and to their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia. The invention also relates to processes for their manufacture and pharmaceutical compositions containing them. | 02-25-2010 |
| 20100099657 | Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity - Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described. | 04-22-2010 |
| 20100137273 | Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions - Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described. | 06-03-2010 |
| 20100168075 | Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions - The application relates to novel 2-azetidinone derivatives of formula (I) and pharmaceutically acceptable salts, solvates and prodrugs thereof. The compounds are cholesterol absorption inhibitors and are useful in the treatment of hyperlipidaemic conditions, including atherosclerosis, Alzheimers' disease and cholesterol associated tumours. The application also relates to pharmaceutical formulations comprising such compounds and to processes for their preparation. | 07-01-2010 |
| 20100216759 | Novel 2-Azetidinone Derivatives And Their Use As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemia - Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described. | 08-26-2010 |
| Patent application number | Description | Published |
|---|
| 20100113961 | MEDICAL DEVICE FOR DETERMINING THE POSTURE OF PATIENT - The present invention relates to a method for determining the posture of a patient. The method comprises the steps of: initiating ( | 05-06-2010 |
| 20100121400 | IMPLANTABLE CARDIAC DEVICE AND METHOD FOR MONITORING THE STATUS OF A CARDIOVASCULAR DISEASE - An implantable cardiac device has a heart stimulator for electrically stimulating the heart of a patient, detector that measures a physiologic parameter that is affected by the status of a cardiovascular disease associated with sympathetic activation, a signal processor that determines at least one of a low frequency, LF, and a very low frequency, VLF, Mayer wave component in the measured parameter, and analyzer that automatically analyzes the determined Mayer wave component in relation to a predetermined reference value to determine the status of the cardiovascular disease. The detector is a cardio-mechanical parameter detector that measures, as said physiologic parameter, a mechanical change in at least one of the four chambers of the heart. In a corresponding method for monitoring the status of a cardiovascular disease associated with sympathetic activation of a patient having an implantable electric heart stimulator a physiologic parameter affected by the cardiac disease is measured. At least one of a low frequency, LF, and a very low frequency, VLF, Mayer wave component in the parameter is determined, and the wave component is analyzed in relation to a predetermined reference value to determine the status of the cardiovascular disease. A mechanical change in at least one of the four chambers of the heart is measured as the physiologic parameter. | 05-13-2010 |
| 20100179411 | IMPLANTABLE MEDICAL DEVICE AND A METHOD COMPRISING MEANS FOR DETECTING AND CLASSIFYING VENTRICULAR TACHYARRHYTMIAS (As Amended) - In a method and implantable medical device for ventricular tachyarrhythmia detection and classification, upon detection of a ventricular tachyarrhythmia based on an electrocardiogram signal, cardiogenic impedance data representative of ventricular volume dynamics are collected and used for classifying the detected tachyarrhythmia as stable or unstable. In the latter case but typically not in the former case, defibrillation shocks or other forms of therapy are applied to combat the unstable ventricular tachyarrhythmia. | 07-15-2010 |
| 20100185252 | DEVICE AND METHOD OF A MEDICAL IMPLANT FOR MONITORING PROGRESSION OF HEART FAILURE IN A HUMAN HEART - In a device and method for a medical implant for monitoring progression of heart failure in a human heart, an activity sensor provides information related to the activity level of a patient and an oxygen sensor provides information related to the level of oxygen content in venous blood. A determined level of venous oxygen content at a determined activity level is obtained, and that level of venous oxygen content is compared to stored values at a corresponding activity level. The result of the comparison is used as a basis for determining a degree of heart failure. | 07-22-2010 |
| 20100268102 | IMPLANTABLE HEART MONITORING DEVICE, SYSTEM AND METHOD - In an implantable heart monitoring device and a monitoring method, an impedance is measured across at least part of an atrium, such that variation of the impedance is related to the volume change of the atrium. Values are stored at different occasions that indicate the rate of change of the measured impedance. The stored values are determined such that, when the device is used in a living being, the variation of the stored values will be related to the variation of the speed with which the atrium is filled with blood during the atrial diastole. | 10-21-2010 |
| 20100298904 | IMPLANTABLE HEART STIMULATOR FOR MEASURING DYSSYNCHRONY USING IMPEDANCE - Implantable heart stimulator connectable to an electrode arrangement has a pulse generator adapted to deliver stimulation pulses to a heart of a subject; an impedance measurement unit adapted monitor at least one heart chamber of the heart of the subject to measure the impedance in the at least one monitored heart chamber for generating an impedance signal corresponding to the measured impedance. The impedance signal is applied to a processor where the signal is processed, according to specified criteria, and a fractionation index value is determined represented by the curve length of the impedance signal during a predetermined measurement period. The fractionation index value is a measure of different degrees of mechanical dyssynchrony of the heart. | 11-25-2010 |
| 20100324432 | METHOD AND DEVICE TO DETECT EATING, TO CONTROL ARTIFICIAL GASTRIC STIMULATION - In a method and device for detecting the intake of food in a subject at least one parameter related to the blood flow and/or perfusion of a blood vessel and/or an organ in the digestive system of a patient is monitored by a sensor attached to, or in, a blood vessel or organ of the digestive system. The value of each monitored parameter is analyzed and may be used to control the activity of a gastric stimulator. | 12-23-2010 |
| 20110144508 | METHOD AND DEVICE FOR MONITORING ACUTE DECOMPENSATED HEART FAILURE - An implantable medical device has an impedance determiner for determining a cardiogenic impedance signal based on electric signals sensed by connected electrodes. A parameter calculator processes the impedance signal to calculate an impedance parameter representative of the cardiogenic impedance in connection with the diastolic phase of a heart cycle. This parameter is then employed by the device for monitoring acute decompensated heart failure status of a subject. | 06-16-2011 |
| Patent application number | Description | Published |
|---|
| 20100196501 | SILVER-CONTAINING FOAM STRUCTURE - A method of producing a hydrophilic polyurethane foam structure containing a silver salt, chosen from the group of silver sulphate, silver citrate, silver acetate, silver carbonate, silver lactate and silver phosphate, or a mixture of these salts includes the steps of (a) providing a water phase containing a surfactant, and at least one silver salt, wherein the at least one silver salt is dispersed in the water phase; (b) providing a isocyanate-terminated polyether having functionality of more than (2); (c) mixing the water phase and the isocyanate-terminated polyether, immediately transferring the resulting mixture to a mould whereby a foam structure is obtained; and (d) drying the foam structure until it has a moisture content of at most 10% (wt). The hydrophilic polyurethane foam structure produced by the method and a wound dressing containing the foam structure are also described. | 08-05-2010 |
| 20100286584 | PARTICLE-CONTAINING FOAM STRUCTURE - A method of producing a hydrophilic polyurethane foam structure containing inert activated carbon particles, includes the steps of: (a) providing a water phase containing a surfactant and dispersed inert particles; (b) providing a isocyanate-terminated polyether having functionality of more than 2; (c) mixing the water phase and the isocyanate-terminated polyether, immediately transferring the resulting mixture to a mould or a continuous web, whereby a foam structure is obtained; and (d) drying the foam structure until it has a moisture content of at most 10% (wt). A foam structure produced by the method and a wound dressing containing the foam structure are also disclosed. | 11-11-2010 |
